Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing Loss
Key facts
- Who runs it
- Zhongshan Hospital Xiamen University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 197 people, planned
- Started
- 1 Jun 2025
- Ended
- 1 Jun 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Vitamin D Supplementation+ standard treatment
- standard treatment
- Record updated
- 4 July 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (2)Hide the full registry criteria
Who can take part
- Clinical diagnosis of Idiopathic Sudden Sensorineural Hearing Loss First-time unilateral occurrence Illness duration ≤14 days No prior treatment
Who cannot take part
- Middle ear lesions, inner ear malformations, or retrocochlear lesion Age <18 years, pregnant or lactating women History of ear surgery or familial hereditary deafness With osteoporosis, osteochondrosis, rickets and other systemic serious systemic diseases Those who refuse to be enrolled
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Clinical Trial Protocol: Investigating the Therapeutic Efficacy of Vitamin D in ISSNHL。Core Research Questions Can vitamin D supplementation improve the prognosis of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)? What potential medical issues might arise during vitamin D administration? Study Design
Read full original descriptionShow less
A controlled trial comparing:
Intervention group: Vitamin D supplementation + standard care Control group: Standard care alone Participant Procedures
Baseline assessment:
Venous blood draw (2 mL) for 25(OH)D level measurement. intervention phase:Daily vitamin D supplementation for 1 month
Endpoint evaluation (1-month follow-up):
Repeat audiometric testing (pure-tone audiometry). Post-treatment 25(OH)D concentration analysis.
The 2 groups in the trial
- Vitamin D SupplementationTreatment being tested
Participants receive Vitamin D3 (dose: 800 IU/day, orally, for 4 weeks)
Treatment: Vitamin D Supplementation+ standard treatment
- Standard CareOther group
Standard treatment
Treatment: standard treatment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Mechanism and Clinical Application of Vitamin D in Influencing the Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
- Record updated
- 4 July 2025